Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | LMNA | P02545 | 4/20 | 0.63 |
| ▸ | GAA | P10253 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10944985 | 0.90 | LMNA (0.71) | ALDH1A1SMN1; SMN2LMNAGAAKMT2A | |
| SCHEMBL5448339 | 0.83 | KMT2A (0.67) | ALDH1A1SMN1; SMN2LMNAGAAKMT2A | |
| SCHEMBL4575974 | 0.83 | LMNA (0.87) | ALDH1A1SMN1; SMN2LMNAGAAKMT2A | |
| SCHEMBL11831458 | 0.83 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNAGAAPOLB | |
| SCHEMBL3958934 | 0.81 | KMT2A (0.80) | ALDH1A1SMN1; SMN2LMNAGAAKMT2A | |
| SCHEMBL17595823 | 0.81 | LMNA (0.79) | ALDH1A1SMN1; SMN2LMNAGAAKMT2A | |
| SCHEMBL7507650 | 0.81 | EPHX1 (0.65) | ALDH1A1SMN1; SMN2LMNAPOLBHTT | |
| SCHEMBL8956279 | 0.80 | KMT2A (0.78) | ALDH1A1SMN1; SMN2LMNAGAAKMT2A | |
| SCHEMBL11438307 | 0.80 | KMT2A (0.77) | ALDH1A1SMN1; SMN2LMNAGAAKMT2A | |
| SCHEMBL5138189 | 0.79 | KMT2A (0.73) | ALDH1A1LMNAGAAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3916074-B1 | SYNERGISTIC ANTIKNOCK FUEL ADDITIVE AND GASOLINE COMPOSITION COMPRISING THE SAME | REPSOL SA (ES) | 2023-07-05 | — | — | EP | disclosed |
| EP-3943580-A1 | GASOLINE COMPOSITION COMPRISING INDOLINE | Repsol, S.A. (ES) | 2022-01-26 | — | — | EP | disclosed |
| WO-2021239755-A1 | SYNERGISTIC ANTIKNOCK FUEL ADDITIVE AND GASOLINE COMPOSITION COMPRISING THE SAME | REPSOL, S.A. (ES) | 2021-12-02 | — | — | WO | disclosed |
| EP-3916074-A1 | SYNERGISTIC ANTIKNOCK FUEL ADDITIVE AND GASOLINE COMPOSITION COMPRISING THE SAME | Repsol, S.A. (ES) | 2021-12-01 | — | — | EP | disclosed |
| CN-105579436-B | Onium salts and compositions comprising the same | 旭化成株式会社 | 2020-12-22 | — | — | CN | disclosed |
| US-10189781-B2 | Onium salt and composition comprising the same | ASAHI KASEI E-MATERIALS CORPORATION (JP) | 2019-01-29 | — | — | US | disclosed |
| US-20160229801-A1 | ONIUM SALT AND COMPOSITION COMPRISING THE SAME | ASAHI KASEI E-MATERIALS CORPORATION (JP) | 2016-08-11 | — | — | US | disclosed |
| US-9028942-B2 | Fluoroelastomer composition and molded article | DAIKIN INDUSTRIES, LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| EP-2607424-A1 | FLUOROELASTOMER COMPOSITION AND MOLDED ARTICLE | Daikin Industries, Ltd. (JP) | 2013-06-26 | — | — | EP | disclosed |
| US-20130150503-A1 | FLUOROELASTOMER COMPOSITION AND MOLDED ARTICLE | DAIKIN INDUSTRIES, LTD. (JP) | 2013-06-13 | — | — | US | disclosed |
| EP-1368029-A4 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | FARRINGTON PHARMACEUTICALS LLC (US) | 2006-02-15 | — | — | EP | disclosed |
| US-20050245512-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | ULRICH PETER C | 2005-11-03 | — | — | US | disclosed |
| US-20050222226-A1 | Five-membered cyclic compounds | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED | 2005-10-06 | — | — | US | disclosed |
| US-6919361-B2 | Five-membered-ring compound | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2005-07-19 | — | — | US | disclosed |
| US-6777557-B2 | Method and composition for rejuvenating cells, tissues organs, hair and nails | FARRINGTON PHARMACEUTICALS, LLC | 2004-08-17 | — | — | US | disclosed |
| US-20040072827-A1 | Five-membered-ring compound | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2004-04-15 | — | — | US | disclosed |
| EP-1368029-A2 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | Farrington Pharmaceuticals, LLC (US) | 2003-12-10 | — | — | EP | disclosed |
| EP-1300401-A1 | FIVE-MEMBERED-RING COMPOUND | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-20020188015-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | FARRINGTON PHARMACEUTICALS, LLC | 2002-12-12 | — | — | US | disclosed |
| WO-2002062301-A2 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | FARRINGTON PHARMACEUTICALS, LLC (US) | 2002-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040072827-A1 | Five-membered-ring compound | EPX, IL5, CCR9 | ALDH1A1 3257/4885SMN1; SMN2 3887/4885LMNA 4315/4885 |
| US-20020188015-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | TERT, TELO2, HKDC1 | ALDH1A1 3396/4885SMN1; SMN2 2608/4885LMNA 820/4885 |
| US-20050245512-A1 | Method and composition for rejuvinating cells, tissues organs, hair and nails | TERT, TELO2, HKDC1 | ALDH1A1 3396/4885SMN1; SMN2 2608/4885LMNA 820/4885 |
| US-20050222226-A1 | Five-membered cyclic compounds | EPX, CCL11, CCR9 | ALDH1A1 3404/4885SMN1; SMN2 3889/4885LMNA 3956/4885 |
| US-10189781-B2 | Onium salt and composition comprising the same | EIF2B5, HSF1, INPP5A | ALDH1A1 3019/4885SMN1; SMN2 1112/4885LMNA 2098/4885 |
| US-20160229801-A1 | ONIUM SALT AND COMPOSITION COMPRISING THE SAME | EIF2B5, HSF1, INPP5A | ALDH1A1 3019/4885SMN1; SMN2 1112/4885LMNA 2098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.